PDCD1 and neoplasm: Conversely, tumors that are devoid of T cells or enriched with immunosuppressive immune cells, such as tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs), are less likely to respond to PD-1/PD-L1 blockade [15].